Page last updated: 2024-08-24

vamicamide and Hepatitis C, Chronic

vamicamide has been researched along with Hepatitis C, Chronic in 1 studies

*Hepatitis C, Chronic: INFLAMMATION of the LIVER in humans that is caused by HEPATITIS C VIRUS lasting six months or more. Chronic hepatitis C can lead to LIVER CIRRHOSIS. [MeSH]

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boujenah, JL; Bourlière, M; Cadranel, JF; Fontanges, T; Ouzan, D; Pol, S; Trepo, C	1

Other Studies

1 other study(ies) available for vamicamide and Hepatitis C, Chronic

Article	Year
Satisfaction of patients treated for chronic hepatitis C with the peginterferon alfa-2b pen device: the VISA observational study. Gastroenterologie clinique et biologique, 2007, Volume: 31, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Female; Hepatitis C, Chronic; Humans; Injections, Subcutaneous; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Patient Compliance; Patient Satisfaction; Polyethylene Glycols; Prospective Studies; Pyridines; Recombinant Proteins; Self Administration; Surveys and Questionnaires	2007

Article

Year

Satisfaction of patients treated for chronic hepatitis C with the peginterferon alfa-2b pen device: the VISA observational study.

Gastroenterologie clinique et biologique, 2007, Volume: 31, Issue:2

Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Female; Hepatitis C, Chronic; Humans; Injections, Subcutaneous; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Patient Compliance; Patient Satisfaction; Polyethylene Glycols; Prospective Studies; Pyridines; Recombinant Proteins; Self Administration; Surveys and Questionnaires

2007